ID29530A - Sediaan obat-obatan untuk penggunaan eksternal menggunakan zat-zat non-steroid anti-peradangan dan analgesik - Google Patents

Sediaan obat-obatan untuk penggunaan eksternal menggunakan zat-zat non-steroid anti-peradangan dan analgesik

Info

Publication number
ID29530A
ID29530A IDW00200100998A ID20010998A ID29530A ID 29530 A ID29530 A ID 29530A ID W00200100998 A IDW00200100998 A ID W00200100998A ID 20010998 A ID20010998 A ID 20010998A ID 29530 A ID29530 A ID 29530A
Authority
ID
Indonesia
Prior art keywords
external use
analgesic
drugs
properties
steroid substances
Prior art date
Application number
IDW00200100998A
Other languages
English (en)
Indonesian (id)
Inventor
Teruhisa Kaneko
Yuka Shinohara
Yoko Kawamura
Masaaki Nagase
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of ID29530A publication Critical patent/ID29530A/id

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/192Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • A61K31/405Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/5415Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IDW00200100998A 1998-11-06 1999-10-28 Sediaan obat-obatan untuk penggunaan eksternal menggunakan zat-zat non-steroid anti-peradangan dan analgesik ID29530A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP10315739A JP2000143540A (ja) 1998-11-06 1998-11-06 非ステロイド系消炎鎮痛薬含有外用剤

Publications (1)

Publication Number Publication Date
ID29530A true ID29530A (id) 2001-09-06

Family

ID=18068965

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW00200100998A ID29530A (id) 1998-11-06 1999-10-28 Sediaan obat-obatan untuk penggunaan eksternal menggunakan zat-zat non-steroid anti-peradangan dan analgesik

Country Status (12)

Country Link
EP (1) EP1126830B1 (pt)
JP (1) JP2000143540A (pt)
CN (1) CN1195504C (pt)
AT (1) ATE401869T1 (pt)
CA (1) CA2348869C (pt)
DE (1) DE69939180D1 (pt)
DK (1) DK1126830T3 (pt)
ES (1) ES2308860T3 (pt)
ID (1) ID29530A (pt)
MY (1) MY130857A (pt)
PT (1) PT1126830E (pt)
WO (1) WO2000027372A1 (pt)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL370889A1 (en) 2001-12-20 2005-05-30 Femmepharma, Inc. Vaginal delivery of drugs
JP5300169B2 (ja) * 2002-03-29 2013-09-25 小林製薬株式会社 フェニル酢酸誘導体類及びメントール類を含有する消炎鎮痛剤及び消炎鎮痛作用増強方法
JP2004131495A (ja) * 2002-09-17 2004-04-30 Nippon Boehringer Ingelheim Co Ltd 非ステロイド系抗炎症剤の局所送達用医薬組成物
EP1578421A4 (en) 2003-01-02 2009-04-22 Femmepharma Holding Co Inc PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF DISEASES AND BREAST CONDITIONS
US9173836B2 (en) 2003-01-02 2015-11-03 FemmeParma Holding Company, Inc. Pharmaceutical preparations for treatments of diseases and disorders of the breast
JP2006069950A (ja) * 2004-09-01 2006-03-16 Tsubaki:Kk 皮膚化粧料
WO2009031318A1 (ja) * 2007-09-05 2009-03-12 Kowa Co., Ltd. 鎮痛・抗炎症剤含有外用剤
JP2009280509A (ja) * 2008-05-20 2009-12-03 Kowa Co 鎮痛・抗炎症剤含有外用剤
BRPI0914687A2 (pt) * 2008-06-24 2015-10-20 Intervet Int Bv preparação veterinária por derramamento, métodos para tratar condições inflamatórias e para administrar a preparação veterinária por derramamento, e, uso da preparação veterinária por derramamento
EP2407179A4 (en) 2009-03-11 2012-09-12 Kowa Co EXTERNAL PREPARATION CONTAINING AN ANALGESIC / ANTI-INFLAMMATORY
US9744132B2 (en) 2010-10-29 2017-08-29 Infirst Healthcare Limited Solid solution compositions and use in chronic inflammation
US10695432B2 (en) 2010-10-29 2020-06-30 Infirst Healthcare Limited Solid solution compositions and use in severe pain
US8895536B2 (en) 2010-10-29 2014-11-25 Infirst Healthcare Ltd. Compositions and methods for treating chronic inflammation and inflammatory diseases
US11224659B2 (en) 2010-10-29 2022-01-18 Infirst Healthcare Limited Solid solution compositions and use in severe pain
US9504664B2 (en) 2010-10-29 2016-11-29 Infirst Healthcare Limited Compositions and methods for treating severe pain
US9271950B2 (en) 2010-10-29 2016-03-01 Infirst Healthcare Limited Compositions for treating chronic inflammation and inflammatory diseases
US9737500B2 (en) 2010-10-29 2017-08-22 Infirst Healthcare Limited Compositions and methods for treating severe pain
US11730709B2 (en) 2010-10-29 2023-08-22 Infirst Healthcare Limited Compositions and methods for treating severe pain
US9308213B2 (en) 2010-10-29 2016-04-12 Infirst Healthcare Limited Solid solution compositions and use in chronic inflammation
US10695431B2 (en) 2010-10-29 2020-06-30 Infirst Healthcare Limited Solid solution compositions and use in cardiovascular disease
US11202831B2 (en) 2010-10-29 2021-12-21 Infirst Healthcare Limited Solid solution compositions and use in cardiovascular disease
JP5358551B2 (ja) * 2010-12-07 2013-12-04 小林製薬株式会社 フェニル酢酸誘導体類及びメントール類を含有する消炎鎮痛剤及び消炎鎮痛作用増強方法
DK2704703T3 (da) 2011-05-03 2019-10-14 Aponia Laboratories Inc Transdermale sammensætninger af ibuprofen og fremgangsmåder til anvendelse deraf
ITMI20111284A1 (it) 2011-07-11 2013-01-12 Giovanni Nusca Composizione farmaceutica.
JP5983183B2 (ja) * 2011-08-26 2016-08-31 ライオン株式会社 外用消炎鎮痛剤製品
JP5820207B2 (ja) 2011-09-13 2015-11-24 日東電工株式会社 経皮吸収促進用組成物および貼付製剤
JP5820206B2 (ja) 2011-09-13 2015-11-24 日東電工株式会社 経皮吸収促進用組成物および貼付製剤
JP6151935B2 (ja) * 2013-03-11 2017-06-21 日東電工株式会社 経皮吸収促進用組成物および貼付製剤
WO2016137411A1 (en) 2015-02-25 2016-09-01 Pharmactive İlaç Sanayi Ve Ticaret A. Ş. Topical spray composition comprising ibuprofen and lidocaine
JP2021063045A (ja) * 2019-10-16 2021-04-22 富士フイルム株式会社 インドメタシン含有乳化液状組成物及び消炎鎮痛用外用液剤
JP2021187770A (ja) * 2020-05-28 2021-12-13 興和株式会社 外用剤

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4537776A (en) * 1983-06-21 1985-08-27 The Procter & Gamble Company Penetrating topical pharmaceutical compositions containing N-(2-hydroxyethyl) pyrrolidone
MY102980A (en) * 1986-10-31 1993-03-31 Pfizer Transdermal flux enhancing compositions
ES2083437T3 (es) * 1989-11-14 1996-04-16 Beta Pharm Co Composiciones anti-inflamatorias para uso externo.
EP0491076A1 (en) * 1990-12-19 1992-06-24 Theratech, Inc. Penetration enhancement with multi-component system of N-aliphatic pyrrolidones with lower alcohols
EP0641760B1 (en) * 1991-08-10 1996-11-06 Hisamitsu Pharmaceutical Co., Inc. Phenylalkanoic acid derivative, production thereof, and separation of optical isomers thereof
US5827886A (en) * 1997-05-07 1998-10-27 Thione International, Inc. Composition for relief of arthritis-induced symptoms

Also Published As

Publication number Publication date
ATE401869T1 (de) 2008-08-15
DE69939180D1 (de) 2008-09-04
MY130857A (en) 2007-07-31
PT1126830E (pt) 2009-08-06
CN1195504C (zh) 2005-04-06
WO2000027372A8 (en) 2000-08-10
CA2348869C (en) 2005-09-20
EP1126830B1 (en) 2008-07-23
ES2308860T3 (es) 2008-12-01
CA2348869A1 (en) 2000-05-18
DK1126830T3 (da) 2008-08-25
CN1354655A (zh) 2002-06-19
EP1126830A4 (en) 2004-10-27
EP1126830A1 (en) 2001-08-29
JP2000143540A (ja) 2000-05-23
WO2000027372A1 (en) 2000-05-18

Similar Documents

Publication Publication Date Title
ID29530A (id) Sediaan obat-obatan untuk penggunaan eksternal menggunakan zat-zat non-steroid anti-peradangan dan analgesik
ES2241575T3 (es) Composiciones farmaceuticas que contienen compuestos con actividad para mejorar la absorcion de ingredientes.
CA2309178A1 (en) Topical compositions for nsai drug delivery
EE04965B1 (et) Imidasoimidasoolid ja triasoolid kui p?letikuvastased hendid, nende kasutamine ravimite valmistamiseks ning farmatseutiline kompositsioon
BR9803300A (pt) Formulação farmacêutica.
NZ509418A (en) Pharmaceutical formulations for aerosols with two or more active substances
ES2197792B1 (es) Formulaciones farmaceuticas que contienen morfina intranasal.
BR9713677A (pt) Formulações em gel para liberação tópica de droga
CO5560580A2 (es) Formulaciones de sucralosa para disumular sabores desagradables
MY101536A (en) Anti-inflammatory and analgesic tape for external use
EP1391200A4 (en) DRUG
WO2002045752A3 (en) Dermal anti-inflammatory composition
BR9913135A (pt) Formulação oral
EP1285667A3 (en) Pharmaceutical injectable solution of paracetamol and combinations of paracetamol with other active substances
DK1280558T3 (da) Halvfast indgivelsesvehikel og farmaceutiske sammensætninger
BR9812553A (pt) Formulação medicamentosa com liberação de substância ativa controlada
SG152257A1 (en) Topical preparation containing ambroxol
DK1225902T3 (da) Ciclesonidholdigt farmaceutisk præparat til administration til slimhinden
ATE353224T1 (de) Abgabeeinrichtung für eine zusammensetzung einer pharmazeutisch wirksamen substanz
BR0007452A (pt) Uso de melagatrano ou de um derivado farmaceuticamente aceitável ou pró-droga do mesmo, método de tratamento de inflamação, e, formulação farmacêutica para uso no tratamento de inflamação
EA200100581A1 (ru) Комбинация анальгетических лекарственных средств
TWI265027B (en) Topical application of muscarinic analgesic drugs such as neostigmine
WO2002000208A3 (de) Kombinationspräparate von 3-n-formylhydroxylaminopropylphosphonsäurederivaten oder 3-n-acetylhydroxylaminopropylphosphonsäurederivaten mit speziellen pharmazeutischen wirkstoffen
DK1152763T3 (da) Anvendelse af desozypeganin til behandling af stofafhængighed
ATE259638T1 (de) Nicht-festes topisch anzuwendendes arzneimittel enthaltend glyzerol und alchemilla vulgaris extrakt